1. Home
  2. SIMO vs NTLA Comparison

SIMO vs NTLA Comparison

Compare SIMO & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIMO
  • NTLA
  • Stock Information
  • Founded
  • SIMO 1995
  • NTLA 2014
  • Country
  • SIMO Hong Kong
  • NTLA United States
  • Employees
  • SIMO N/A
  • NTLA N/A
  • Industry
  • SIMO Semiconductors
  • NTLA Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • SIMO Technology
  • NTLA Health Care
  • Exchange
  • SIMO Nasdaq
  • NTLA Nasdaq
  • Market Cap
  • SIMO 1.8B
  • NTLA 1.4B
  • IPO Year
  • SIMO 2005
  • NTLA 2016
  • Fundamental
  • Price
  • SIMO $54.62
  • NTLA $12.22
  • Analyst Decision
  • SIMO Strong Buy
  • NTLA Buy
  • Analyst Count
  • SIMO 9
  • NTLA 17
  • Target Price
  • SIMO $81.67
  • NTLA $56.63
  • AVG Volume (30 Days)
  • SIMO 257.6K
  • NTLA 2.3M
  • Earning Date
  • SIMO 02-04-2025
  • NTLA 02-20-2025
  • Dividend Yield
  • SIMO 3.67%
  • NTLA N/A
  • EPS Growth
  • SIMO 58.68
  • NTLA N/A
  • EPS
  • SIMO 2.64
  • NTLA N/A
  • Revenue
  • SIMO $814,771,000.00
  • NTLA $43,086,000.00
  • Revenue This Year
  • SIMO $29.10
  • NTLA $52.50
  • Revenue Next Year
  • SIMO $6.02
  • NTLA $0.42
  • P/E Ratio
  • SIMO $20.48
  • NTLA N/A
  • Revenue Growth
  • SIMO 27.80
  • NTLA N/A
  • 52 Week Low
  • SIMO $50.50
  • NTLA $11.34
  • 52 Week High
  • SIMO $85.87
  • NTLA $34.87
  • Technical
  • Relative Strength Index (RSI)
  • SIMO 48.19
  • NTLA 40.01
  • Support Level
  • SIMO $53.39
  • NTLA $11.34
  • Resistance Level
  • SIMO $56.85
  • NTLA $12.30
  • Average True Range (ATR)
  • SIMO 2.12
  • NTLA 0.67
  • MACD
  • SIMO -0.27
  • NTLA 0.01
  • Stochastic Oscillator
  • SIMO 33.84
  • NTLA 32.47

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is active in the semiconductor industry and focuses on designing, developing, and marketing of controllers for managing NAND flash used in embedded storage applications, such as eMMC embedded memory. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: